Our research suggests that S100A6 could promote the proliferation and migration of HCCby increasing the degradation and ubiquitination of p53, which reveals a new mechanismof S100A6 in HCC development, thus offering a potent therapeutic target for HCCtreatment. Here, S100A6 is linked to hepatocellular carcinoma.